136 related articles for article (PubMed ID: 10554372)
1. T3N0 rectal cancer: results following sharp mesorectal excision and no adjuvant therapy.
Merchant NB; Guillem JG; Paty PB; Enker WE; Minsky BD; Quan SH; Wong D; Cohen AM
J Gastrointest Surg; 1999; 3(6):642-7. PubMed ID: 10554372
[TBL] [Abstract][Full Text] [Related]
2. Local recurrence after 'standard' abdominoperineal resection: do we really need ELAPE?
Xanthis A; Greenberg D; Jha B; Olafimihan O; Miller R; Fearnhead N; Davies J; Hall N
Ann R Coll Surg Engl; 2018 Feb; 100(2):111-115. PubMed ID: 29022795
[TBL] [Abstract][Full Text] [Related]
3. The impact of mesorectal fat area on recurrence following total mesorectal excision for lower rectal cancer.
Shioi I; Yamaoka Y; Shiomi A; Kagawa H; Hino H; Manabe S; Chen K; Nanishi K; Notsu A
Langenbecks Arch Surg; 2023 Apr; 408(1):147. PubMed ID: 37046049
[TBL] [Abstract][Full Text] [Related]
4. Prognostic determinants of patients with lateral nodal involvement by rectal cancer.
Ueno H; Mochizuki H; Hashiguchi Y; Hase K
Ann Surg; 2001 Aug; 234(2):190-7. PubMed ID: 11505064
[TBL] [Abstract][Full Text] [Related]
5. The effect of rectal washout on local recurrence following rectal cancer surgery.
Moosvi SR; Manley K; Hernon J
Ann R Coll Surg Engl; 2018 Feb; 100(2):146-151. PubMed ID: 29181995
[TBL] [Abstract][Full Text] [Related]
6. Recurrence and Survival of Neuroendocrine Neoplasms of the Rectum: Single-Center Experience.
Storino A; Wong D; Ore AS; Gaytan-Fuentes IA; Fabrizio A; Cataldo T; Messaris E
J Gastrointest Surg; 2021 Sep; 25(9):2398-2400. PubMed ID: 33269457
[TBL] [Abstract][Full Text] [Related]
7. Extent of mesorectal tumor invasion as a prognostic factor after curative surgery for T3 rectal cancer patients.
Miyoshi M; Ueno H; Hashiguchi Y; Mochizuki H; Talbot IC
Ann Surg; 2006 Apr; 243(4):492-8. PubMed ID: 16552200
[TBL] [Abstract][Full Text] [Related]
8. Incidence and Risk Factors for Low Anterior Resection Syndrome following Trans-Anal Total Mesorectal Excision.
Parnasa SY; Mizrahi I; Helou B; Cohen A; Abu Gazala M; Pikarsky AJ; Shussman N
J Clin Med; 2024 Jan; 13(2):. PubMed ID: 38256571
[TBL] [Abstract][Full Text] [Related]
9. Completion Total Mesorectal Excision: A Case-Matched Comparison With Primary Resection.
Burghgraef TA; Rutgers ML; Leijtens JWA; Tuyman JB; Consten ECJ; Hompes R
Ann Surg Open; 2023 Sep; 4(3):e327. PubMed ID: 37746593
[TBL] [Abstract][Full Text] [Related]
10. A critical reappraisal for the value of tumor size as a prognostic variable in rectal adenocarcinoma.
Chen CH; Hsieh MC; Hsiao PK; Lin EK; Lu YJ; Wu SY
J Cancer; 2017; 8(10):1927-1934. PubMed ID: 28819391
[No Abstract] [Full Text] [Related]
11. Recent advances in the management of carcinoma of the rectum.
Basu S; Srivastava V; Shukla VK
Clin Exp Gastroenterol; 2009; 2():49-60. PubMed ID: 21694827
[TBL] [Abstract][Full Text] [Related]
12. Continued Improvement in Rectal Cancer Survival Outcomes Will Require True Multidisciplinary Treatment Approaches.
Cohen S; Bordeianou L
J Gastrointest Surg; 2020 Mar; 24(3):742-747. PubMed ID: 31848869
[TBL] [Abstract][Full Text] [Related]
13. Long recurrence-free survival of localized rectal melanoma after abdominoperineal resection in comparison to partial excision and highlighting the place of immunotherapy: A case report.
Bourouail O; Njoumi N; Elmahdaouy Y; Fahssi M; Yaka M; Hejjouji A; Ali AA
JRSM Open; 2023 Feb; 14(2):20542704221148059. PubMed ID: 36762266
[TBL] [Abstract][Full Text] [Related]
14. Late Local Recurrence after Neoadjuvant Therapy and Radical Resection for Locally Advanced Rectal Cancer.
Salega A; Münch M; Renner P; Thon KP; Steurer W; Mönch D; Koch J; Maaß A; Schlitt HJ; Dahlke MH; Leibold T
Cancers (Basel); 2024 Jan; 16(2):. PubMed ID: 38275889
[TBL] [Abstract][Full Text] [Related]
15. Risk factors affecting oncological outcomes of surgical resections for middle and lower rectal cancer.
Tırnova İ; Işık Ö; Yılmazlar AT
Turk J Surg; 2023 Sep; 39(3):197-203. PubMed ID: 38058368
[TBL] [Abstract][Full Text] [Related]
16. Biology-and Location-Oriented Precision Treatment of Rectal Cancer: Present and Future.
Fichtner-Feigl S
Visc Med; 2020 Oct; 36(5):381-387. PubMed ID: 33178735
[TBL] [Abstract][Full Text] [Related]
17. Laryngeal metastasis 4 years after primary rectal cancer resection.
Huang H; Li L; Cao Q; Jiang H; Li J
Am J Med Sci; 2023 Jul; 366(1):e11. PubMed ID: 36965519
[No Abstract] [Full Text] [Related]
18. Comment on: Beyond the transanal total mesorectal excision moratorium: local and distant recurrence among patients operated for low rectal tumours-5-year follow-up from a Norwegian University Hospital.
Wasmuth H; Gachabayov M; Lee H; Barzola E; Javadov M; Cianchi F; Nasseri Y; Barnajian M; Popa DE; Bergamaschi R
Br J Surg; 2024 Jan; 111(1):. PubMed ID: 38205613
[No Abstract] [Full Text] [Related]
19. Author response to: Comment on: Beyond the transanal total mesorectal excision moratorium: local and distant recurrence among patients operated for low rectal tumours-5-year follow-up from a Norwegian University Hospital.
Riis RN; Augestad KM
Br J Surg; 2024 Jan; 111(1):. PubMed ID: 38205614
[No Abstract] [Full Text] [Related]
20. Beyond the transanal total mesorectal excision moratorium: local and distant recurrence among patients operated for low rectal tumours-5-year follow-up from a Norwegian University Hospital.
Riis RN; Riis MH; Benth JŠ; Augestad KM
Br J Surg; 2023 Oct; 110(11):1547-1548. PubMed ID: 37672389
[No Abstract] [Full Text] [Related]
[Next] [New Search]
